Transcatheter aortic valve replacement is approved for the first time for asymptomatic aortic stenosis.
The U.S. Food and Drug Administration (FDA) has granted the first approval for transcatheter aortic valve replacement (TAVR) for asymptomatic, severe aortic stenosis. The SAPIEN system has been licensed…